The trial had 24 patients, exceeding the original target of 20, and included a 4-week baseline. ・In the Absence cohort, patients experienced a median 73.1% reduction in seizures. ・The DEE cohort saw a ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

Biosciences announced positive and significant topline results from its Phase 2 BREAKTHROUGH clinical trial evaluating ...

Bright Minds Biosciences (DRUG) stock jumps as lead drug BMB-101 succeeds in a mid-stage trial against a severe neurological ...

The first seizure clinic model enabled rapid diagnosis and treatment for children with epilepsy, according to data presented ...

Gemma Atkinson has openly shared why she hasn't yet married her Spanish fiancé, Strictly pro dancer Gorka Marquez, despite being parents to two children, Mia and Thiago. In a touching open letter ...

THAT IS. AND IT’S TIME FOR NEWS TO GO. WE’VE GOT A LOOK AT TODAY’S TOP NEWS STORIES, TRAFFIC AND WEATHER ALL BEFORE YOU HEAD OUT THE DOOR. WE START WITH OUR RACHEL HERXHEIMER IN WASHINGTON, WHERE TWO ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

Taking the pain medication tramadol along with some common antidepressants could raise seizure risk in older adults, a new study has warned. The research, published in the journal Neurology, found ...